This video does not constitute an offer or solicitation of an offer to invest in the CKV Co-Fund. It simply introduces a potential investment opportunity.
The investment opportunity described in this video is not available to the public and is restricted to persons who qualify under relevant exclusions from the Financial Markets Conduct Act 2013 or similar exclusions for any other applicable jurisdiction.
Since 2008, Cure Kids Ventures (CKV) has invested in a portfolio of companies with products and services covering medical devices, medications, diagnostics, health information and healthcare delivery systems.
As a predominant investor in New Zealand’s seed and early stage healthcare and biotech sector, CKV has established a reputation in the investment community as an informed and value added investor. In addition to investment funds, we provide investee companies with healthcare industry specific expertise and access to industry networks.
CKV has recently launched the CKV Co-Fund 1 to enable investors who are interested in emerging healthcare companies to invest alongside CKV. We are also an approved partner of the New Zealand Government’s Venture Investment Fund (NZVIF) Seed Co-Investment Programme, which invests alongside CKV.
Our wide connections to medical research institutes, universities and industry organisations facilitate and enhance deal flow for investments.
Our team has global experience in the biotech, healthcare and medical devices industry. We have a highly desired blend of skills in early stage company development, intellectual property commercialisation, global expansion, science, finance and mergers and acquisitions.
Cure Kids Ventures is a vital part of Cure Kids’ vision for a healthy childhood for everyone.